BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cequent Pharmaceuticals, Inc. 

One Kendall Square
Building 700, First Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-995-7940 Fax: 617-995-7941


SEARCH JOBS





Segment
Start Up





 Company News
MDRNA, Inc. Shareholders Approve Acquisition of Cequent Pharmaceuticals, Inc. 7/22/2010 10:12:32 AM
Cequent Pharmaceuticals, Inc. Announces European Patent Office Intent to Grant and Korean Patent Office Notice of Decision to Award First Patents Covering tkRNAi Therapeutics 6/22/2010 11:44:29 AM
Cequent Pharmaceuticals, Inc. Begins Chronic Toxicology Study with CEQ508, Lead Oncology tkRNAi Drug Candidate 4/15/2010 10:23:08 AM
MDRNA, Inc. to Buy Privately Held Cequent Pharmaceuticals, Inc. for $46 Million 4/1/2010 6:29:58 AM
FDA Grants Cequent Pharmaceuticals, Inc. IND 12/10/2009 11:25:26 AM
Cequent Pharmaceuticals, Inc. Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology First Orally Delivered RNAi Investigational Drug to be Tested in Humans 11/12/2009 8:46:29 AM
Cequent Pharmaceuticals, Inc. Closes Tranche of $10.8 Million Round 11/2/2009 8:04:11 AM
Cequent Pharmaceuticals, Inc. to Provide Details at BIOCOM About Planned Launch of its Clinical Program 10/13/2009 8:43:10 AM
Cequent Pharmaceuticals, Inc. Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases 6/2/2009 11:42:33 AM
Cequent Pharmaceuticals, Inc. tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research 4/16/2009 11:51:10 AM
123